About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- ALS causes progressive UMN and LMN signs with spared sensation
- EMG supports diagnosis
- riluzole modestly prolongs survival
- noninvasive ventilation improves outcomes
Overview
Amyotrophic Lateral Sclerosis is a high-yield neurology condition for USMLE Step 2 CK. The central task is to recognize the classic presentation, localize the lesion or syndrome, exclude dangerous mimics, and choose the next best diagnostic or management step.
Epidemiology
Risk factors, age distribution, and common mimics vary by syndrome. USMLE questions often test pattern recognition, red flags, first-line diagnostic tests, and treatment contraindications.
Clinical Features
Symptoms
Painless progressive weakness, cramps, fasciculations, dysarthria, dysphagia, dyspnea
Progressive or severe symptoms require urgent reassessment
Functional impairment is common
Systemic features or red flags suggest secondary pathology
Medication and comorbidity history guide differential
Signs
Focused neurological examination localizes the lesion
Motor, sensory, reflex, cranial nerve, gait, and autonomic findings should be documented
Objective deficits increase urgency
Normal examination supports a benign primary syndrome when history is classic
Atypical signs require imaging or specialist review
Investigations
First-line
EMG/NCS plus MRI brain/cervical spine and mimic labsCore diagnostic approach for this condition
Focused neurological examLocalizes lesion and identifies red flags
Medication/risk factor reviewIdentifies common mimics and precipitants
Second-line
MRI or targeted imagingUsed when red flags, atypical features, structural disease, or surgical planning
Laboratory testingUsed to evaluate metabolic, infectious, inflammatory, or systemic causes
Electrodiagnostic or functional testingUsed when localization or severity is uncertain
Specialist
Specialist referralIndicated for progressive, refractory, atypical, or emergency presentations
Serial monitoringTracks neurological function and treatment response
1
Initial management
- Riluzole, edaravone selected, NIV, nutrition/PEG, PT/OT, palliative care
- Address pain, safety, function, and reversible contributors
- Escalate urgently when red flags are present
- Educate on expected course and return precautions
2
Definitive therapy
- Treat the underlying cause when identified
- Use disease-specific medication or procedure when indicated
- Reassess response and adverse effects
- Coordinate neurology/neurosurgery/ophthalmology where appropriate
3
Supportive care
- Physical/occupational therapy when function affected
- Fall, driving, swallowing, vision, and medication safety as relevant
- Manage comorbid mood, sleep, and pain
- Patient education and follow-up
4
Escalation
- Emergency imaging for acute neurological deterioration
- Hospitalize if airway, vision, cord, infection, or severe weakness risk
- Specialist intervention for refractory or progressive disease
- Reconsider diagnosis if treatment response is atypical
Complications
- Permanent neurological deficit: Risk increases when progressive deficits are missed
- Functional impairment: Pain, weakness, gait, vision, or cognition may limit independence
- Treatment adverse effects: Monitor disease-specific medications and procedures
- Misdiagnosis: Atypical features should trigger reconsideration and imaging
USMLE Step 2 CK Exam Tips
- 1UMN + LMN + normal sensation = ALS
- 2bowel/bladder early suggests cord lesion
- 3EMG supports diagnosis
- 4riluzole modestly prolongs survival
- 5noninvasive ventilation improves outcomes
- 6noninvasive ventilation improves outcomes
- 7noninvasive ventilation improves outcomes
practicetest your knowledge on amyotrophic lateral sclerosisApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — neurology and beyond.
open q-bank